Provided by Tiger Trade Technology Pte. Ltd.

Evolus Inc.

7.85
-0.0650-0.82%
Volume:72.14K
Turnover:576.95K
Market Cap:516.63M
PE:-14.90
High:8.15
Open:8.01
Low:7.83
Close:7.91
52wk High:9.31
52wk Low:3.86
Shares:65.85M
Float Shares:47.53M
Volume Ratio:0.38
T/O Rate:0.15%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5267
EPS(LYR):-0.8010
ROE:-18729.61%
ROA:-5.68%
PB:-16.72
PE(LYR):-9.79

Loading ...

Evolus Expands Strategic Partnership with Symatese to Commercialize Estyme® in Canada, Australia, and New Zealand

THOMSON REUTERS
·
Aug 04

Evolus - Agreement Expected to be Accretive to Evolus International Gross Margins

THOMSON REUTERS
·
Aug 04

Evolus - to Commercialize Estyme in All Markets with Jeuveau and Nuceiva in 2028

THOMSON REUTERS
·
Aug 04

Evolus - to Pay Upfront, Milestone Payments and Mid-Single Digit Royalty to Symatese

THOMSON REUTERS
·
Aug 04

Evolus Inc Expected to Post a Loss of 3 Cents a Share - Earnings Preview

Reuters
·
Aug 04

Evolus to Report Second-quarter Results After Markets Close, Host Conference Call

Reuters
·
Jul 22

Evolus Reports 115,000 RSU Inducement Grants to 38 New Hires Under 2023 Plan

Reuters
·
Jul 11

Evolus Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Jul 11

Analysts’ Top Healthcare Picks: Evolus (EOLS), Annovis Bio (ANVS)

TIPRANKS
·
Jul 09

Analysts Have Conflicting Sentiments on These Healthcare Companies: Evolus (EOLS), Alkermes (ALKS) and VolitionRX (VNRX)

TIPRANKS
·
Jul 08

Evolus partners with IBSA to develop and market Profhilo in the U.S.

TIPRANKS
·
Jul 08

Evolus Partners with IBSA to License, Distribute Profhilo in US

Reuters
·
Jul 08

Evolus - Agreement not Expected to Impact 2026 or 2028 Financial Targets

THOMSON REUTERS
·
Jul 08

Evolus - Under Terms, Co to Lead U.S. Regulatory Approval and Commercialization of Profhilo

THOMSON REUTERS
·
Jul 08

Evolus Announces Partnership with Ibsa to Develop and Commercialize Market-leading Profhilo® in the United States, Expanding Its Injectable Portfolio into Skin Quality

THOMSON REUTERS
·
Jul 08

Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX) and Evolus (EOLS)

TIPRANKS
·
Jul 02

Evolus Price Target Maintained With a $13.00/Share by BTIG

Dow Jones
·
Jun 17

Evolus shareholders elect Brady Stewart, Vikram Malik as Class II directors

Reuters
·
Jun 13

Evolus (EOLS) Receives a Buy from Mizuho Securities

TIPRANKS
·
Jun 09

Evolus files $250M mixed securities shelf

TIPRANKS
·
Jun 06